Based on the Antibody Drug Conjugates market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Antibody Drug Conjugates market covered in Chapter 5:
Oxford BioTherapeutics
ImmunoGen
Celldex Therapeutics
Millennium Pharmaceuticals
Seattle Genetics
Mersana Therapeutics
Immunomedics
Bayer HealthCare
Heidelberg Pharma
Pfizer
In Chapter 6, on the basis of types, the Antibody Drug Conjugates market from 2015 to 2025 is primarily split into:
Cleavable Linker
Non-cleavable Linker
In Chapter 7, on the basis of applications, the Antibody Drug Conjugates market from 2015 to 2025 covers:
Blood Cancer
Breast Cancer
Ovarian Cancer
Lung Cancer
Brain Tumor
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Antibody Drug Conjugates Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Oxford BioTherapeutics
5.1.1 Oxford BioTherapeutics Company Profile
5.1.2 Oxford BioTherapeutics Business Overview
5.1.3 Oxford BioTherapeutics Antibody Drug Conjugates Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Oxford BioTherapeutics Antibody Drug Conjugates Products Introduction
5.2 ImmunoGen
5.2.1 ImmunoGen Company Profile
5.2.2 ImmunoGen Business Overview
5.2.3 ImmunoGen Antibody Drug Conjugates Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 ImmunoGen Antibody Drug Conjugates Products Introduction
5.3 Celldex Therapeutics
5.3.1 Celldex Therapeutics Company Profile
5.3.2 Celldex Therapeutics Business Overview
5.3.3 Celldex Therapeutics Antibody Drug Conjugates Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Celldex Therapeutics Antibody Drug Conjugates Products Introduction
5.4 Millennium Pharmaceuticals
5.4.1 Millennium Pharmaceuticals Company Profile
5.4.2 Millennium Pharmaceuticals Business Overview
5.4.3 Millennium Pharmaceuticals Antibody Drug Conjugates Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Millennium Pharmaceuticals Antibody Drug Conjugates Products Introduction
5.5 Seattle Genetics
5.5.1 Seattle Genetics Company Profile
5.5.2 Seattle Genetics Business Overview
5.5.3 Seattle Genetics Antibody Drug Conjugates Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Seattle Genetics Antibody Drug Conjugates Products Introduction
5.6 Mersana Therapeutics
5.6.1 Mersana Therapeutics Company Profile
5.6.2 Mersana Therapeutics Business Overview
5.6.3 Mersana Therapeutics Antibody Drug Conjugates Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Mersana Therapeutics Antibody Drug Conjugates Products Introduction
5.7 Immunomedics
5.7.1 Immunomedics Company Profile
5.7.2 Immunomedics Business Overview
5.7.3 Immunomedics Antibody Drug Conjugates Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Immunomedics Antibody Drug Conjugates Products Introduction
5.8 Bayer HealthCare
5.8.1 Bayer HealthCare Company Profile
5.8.2 Bayer HealthCare Business Overview
5.8.3 Bayer HealthCare Antibody Drug Conjugates Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Bayer HealthCare Antibody Drug Conjugates Products Introduction
5.9 Heidelberg Pharma
5.9.1 Heidelberg Pharma Company Profile
5.9.2 Heidelberg Pharma Business Overview
5.9.3 Heidelberg Pharma Antibody Drug Conjugates Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Heidelberg Pharma Antibody Drug Conjugates Products Introduction
5.10 Pfizer
5.10.1 Pfizer Company Profile
5.10.2 Pfizer Business Overview
5.10.3 Pfizer Antibody Drug Conjugates Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Pfizer Antibody Drug Conjugates Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Antibody Drug Conjugates Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Antibody Drug Conjugates Sales and Market Share by Types (2015-2020)
6.1.2 Global Antibody Drug Conjugates Revenue and Market Share by Types (2015-2020)
6.1.3 Global Antibody Drug Conjugates Price by Types (2015-2020)
6.2 Global Antibody Drug Conjugates Market Forecast by Types (2020-2025)
6.2.1 Global Antibody Drug Conjugates Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Antibody Drug Conjugates Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Antibody Drug Conjugates Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Antibody Drug Conjugates Sales, Price and Growth Rate of Cleavable Linker
6.3.2 Global Antibody Drug Conjugates Sales, Price and Growth Rate of Non-cleavable Linker
6.4 Global Antibody Drug Conjugates Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Cleavable Linker Market Revenue and Sales Forecast (2020-2025)
6.4.2 Non-cleavable Linker Market Revenue and Sales Forecast (2020-2025)
7 Market Analysis and Forecast, By Applications
7.1 Global Antibody Drug Conjugates Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Antibody Drug Conjugates Sales and Market Share by Applications (2015-2020)
7.1.2 Global Antibody Drug Conjugates Revenue and Market Share by Applications (2015-2020)
7.2 Global Antibody Drug Conjugates Market Forecast by Applications (2020-2025)
7.2.1 Global Antibody Drug Conjugates Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Antibody Drug Conjugates Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Antibody Drug Conjugates Revenue, Sales and Growth Rate of Blood Cancer (2015-2020)
7.3.2 Global Antibody Drug Conjugates Revenue, Sales and Growth Rate of Breast Cancer (2015-2020)
7.3.3 Global Antibody Drug Conjugates Revenue, Sales and Growth Rate of Ovarian Cancer (2015-2020)
7.3.4 Global Antibody Drug Conjugates Revenue, Sales and Growth Rate of Lung Cancer (2015-2020)
7.3.5 Global Antibody Drug Conjugates Revenue, Sales and Growth Rate of Brain Tumor (2015-2020)
7.4 Global Antibody Drug Conjugates Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Blood Cancer Market Revenue and Sales Forecast (2020-2025)
7.4.2 Breast Cancer Market Revenue and Sales Forecast (2020-2025)
7.4.3 Ovarian Cancer Market Revenue and Sales Forecast (2020-2025)
7.4.4 Lung Cancer Market Revenue and Sales Forecast (2020-2025)
7.4.5 Brain Tumor Market Revenue and Sales Forecast (2020-2025)
8 Market Analysis and Forecast, By Regions
8.1 Global Antibody Drug Conjugates Sales by Regions (2015-2020)
8.2 Global Antibody Drug Conjugates Market Revenue by Regions (2015-2020)
8.3 Global Antibody Drug Conjugates Market Forecast by Regions (2020-2025)
9 North America Antibody Drug Conjugates Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Antibody Drug Conjugates Market Sales and Growth Rate (2015-2020)
9.3 North America Antibody Drug Conjugates Market Revenue and Growth Rate (2015-2020)
9.4 North America Antibody Drug Conjugates Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Antibody Drug Conjugates Market Analysis by Country
9.6.1 U.S. Antibody Drug Conjugates Sales and Growth Rate
9.6.2 Canada Antibody Drug Conjugates Sales and Growth Rate
9.6.3 Mexico Antibody Drug Conjugates Sales and Growth Rate
10 Europe Antibody Drug Conjugates Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Antibody Drug Conjugates Market Sales and Growth Rate (2015-2020)
10.3 Europe Antibody Drug Conjugates Market Revenue and Growth Rate (2015-2020)
10.4 Europe Antibody Drug Conjugates Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Antibody Drug Conjugates Market Analysis by Country
10.6.1 Germany Antibody Drug Conjugates Sales and Growth Rate
10.6.2 United Kingdom Antibody Drug Conjugates Sales and Growth Rate
10.6.3 France Antibody Drug Conjugates Sales and Growth Rate
10.6.4 Italy Antibody Drug Conjugates Sales and Growth Rate
10.6.5 Spain Antibody Drug Conjugates Sales and Growth Rate
10.6.6 Russia Antibody Drug Conjugates Sales and Growth Rate
11 Asia-Pacific Antibody Drug Conjugates Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Antibody Drug Conjugates Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Antibody Drug Conjugates Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Antibody Drug Conjugates Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Antibody Drug Conjugates Market Analysis by Country
11.6.1 China Antibody Drug Conjugates Sales and Growth Rate
11.6.2 Japan Antibody Drug Conjugates Sales and Growth Rate
11.6.3 South Korea Antibody Drug Conjugates Sales and Growth Rate
11.6.4 Australia Antibody Drug Conjugates Sales and Growth Rate
11.6.5 India Antibody Drug Conjugates Sales and Growth Rate
12 South America Antibody Drug Conjugates Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Antibody Drug Conjugates Market Sales and Growth Rate (2015-2020)
12.3 South America Antibody Drug Conjugates Market Revenue and Growth Rate (2015-2020)
12.4 South America Antibody Drug Conjugates Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Antibody Drug Conjugates Market Analysis by Country
12.6.1 Brazil Antibody Drug Conjugates Sales and Growth Rate
12.6.2 Argentina Antibody Drug Conjugates Sales and Growth Rate
12.6.3 Columbia Antibody Drug Conjugates Sales and Growth Rate
13 Middle East and Africa Antibody Drug Conjugates Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Antibody Drug Conjugates Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Antibody Drug Conjugates Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Antibody Drug Conjugates Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Antibody Drug Conjugates Market Analysis by Country
13.6.1 UAE Antibody Drug Conjugates Sales and Growth Rate
13.6.2 Egypt Antibody Drug Conjugates Sales and Growth Rate
13.6.3 South Africa Antibody Drug Conjugates Sales and Growth Rate
14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 Appendix
15.1 Methodology
15.2 Research Data Source
List of Tables and Figures
Figure Product Picture
Figure Global Antibody Drug Conjugates Market Size and Growth Rate 2015-2025
Table Antibody Drug Conjugates Key Market Segments
Figure Global Antibody Drug Conjugates Market Revenue ($) Segment by Type from 2015-2020
Figure Global Antibody Drug Conjugates Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Antibody Drug Conjugates
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Oxford BioTherapeutics Company Profile
Table Oxford BioTherapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Oxford BioTherapeutics Production and Growth Rate
Summary: Get latest Market Research Reports on Antibody Drug Conjugates. Industry analysis & Market Report on Antibody Drug Conjugates is a syndicated market report, published as Global Antibody Drug Conjugates Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Antibody Drug Conjugates market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.